• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to footer
BlackDoctor.org
Where Wellness & Culture Connect

Where Wellness & Culture Connect

  • Conditions
  • Wellness
  • Lifestyle
  • Longevity
  • Clinical Trials
  • Resources
    • Generational Health
    • Top Blacks in Healthcare 2025
    • Hall Of Fame
    • Clinical Trials Resource Center
    • Obesity Resource Center
    • Cancer Resource Center
    • Wellness on the Yard
    • Immunocompromised Care
    • BDO Resource Library
  • Find A Doctor
  • BDO TV
Home / Health Conditions / Clinical Trials / Why Aren’t More Men Participating in Lifesaving Clinical Trials?

Why Aren’t More Men Participating in Lifesaving Clinical Trials?

Why Aren't More Men Participating in Lifesaving Clinical Trials?

A recent study has shed light on a persistent problem in health research: the underrepresentation of men in behavioral clinical trials, particularly those focused on lifestyle interventions. The research, published in Trials, looked at data from the Enhanced Lifestyles for Metabolic Syndrome (ELM) trial, a behavioral clinical trial targeting lifestyle change and remission of metabolic syndromes like obesity and high blood pressure, to investigate factors associated with male recruitment. The findings underscore the need for tailored recruitment strategies that address the specific reasons why men may be less likely to participate in such studies.

Metabolic syndrome, a cluster of conditions that increase the risk of heart disease, stroke, and diabetes, affects a significant portion of the population. Lifestyle changes, including diet and exercise, are crucial for managing and even reversing this condition. Behavioral clinical trials play a vital role in developing and evaluating effective interventions. However, the lack of male participation in these trials can limit how far these interventions go in preventing disease.

Key Findings and Implications

One of the most significant findings of the study was that men were more likely to drop out of the recruitment process at earlier stages compared to women. Specifically, a smaller proportion of men (58.3%) attended the in-person information session compared to women (66.5%). This suggests that initial engagement and interest are critical factors in male recruitment. Once men attended the information session, the proportion that moved forward through the remaining screening steps was similar to women, indicating that the primary challenge lies in capturing their initial interest and getting them to engage with the study in the first place.

You May Also Like
Psoriatic Arthritis Can Feel Beyond Your Control. Consider a Different Direction. Learn More Here. Psoriatic Arthritis Can Feel Beyond Your Control. Consider a Different Direction. Learn More Here.

This finding has important implications for recruitment strategies. It suggests that efforts to increase male enrollment should focus on enhancing initial outreach and communication. This could involve using different communication channels, tailoring messaging to resonate with men’s specific concerns and motivations, and making the initial steps of the recruitment process as easy and accessible as possible.

Another key finding was the association between self-awareness of health risk and participation among men. The study suggests that men who were more aware of their own health risks were more likely to express interest in the trial. This highlights the importance of raising awareness about metabolic syndrome and its associated risks among men. Public health campaigns and targeted outreach efforts could play a crucial role in increasing men’s understanding of their health status and motivating them to seek out and participate in relevant research.

Tailoring recruitment efforts to the specific needs and interests of each sex is essential for maximizing participation. This could involve using different messaging, targeting different communication channels, and offering different types of incentives.

You May Also Like
Get GLP-1s Delivered to You As Low As $99/Month! Get GLP-1s Delivered to You As Low As $99/Month!

Recommendations for Future Research and Practice

Based on these findings, the researchers recommend several key strategies for improving male recruitment in behavioral clinical trials:

  • Focus on early engagement: Prioritize strategies that enhance initial interest and engagement among men. This could involve using targeted advertising, social media campaigns, and partnerships with community organizations that serve men.
  • Raise awareness of health risks: Implement public health campaigns and targeted outreach efforts to increase men’s awareness of metabolic syndrome and its associated risks.
  • Tailor recruitment strategies: Develop sex-specific recruitment strategies that address the unique needs and motivations of men and women.
  • Simplify the recruitment process: Make the initial steps of the recruitment process as easy and accessible as possible to minimize barriers to participation.

By addressing these challenges and implementing targeted recruitment strategies, researchers can improve male representation in behavioral clinical trials, leading to more generalizable findings and the development of more effective interventions for men’s health. This study serves as a valuable reminder that understanding the specific factors influencing participation among different demographic groups is crucial for conducting rigorous and impactful health research.

By Team BlackDoctor.org | Published August 7, 2025

August 7, 2025 by Team BlackDoctor.org

The Latest In Clinical Trials

radiation therapy

Can You Safely Skip Radiation Therapy?

Radiation therapy might not be necessary for treating some forms of rectal cancer and lymphoma, sparing patients from the toxic treatment, a pair of new clinical trials show. One trial found that rectal cancer patients whose tumors shrink in response read more about Can You Safely Skip Radiation Therapy?
multiple myeloma

Three Opportunities to Potentially Improve Multiple Myeloma Care for Black Patients

Sponsored by GSK Multiple myeloma is a cancer that affects a person’s plasma cells, which helps the body fight infection and disease. It can permanently weaken bones and damage organs,1 and it’s the most common blood cancer in people of read more about Three Opportunities to Potentially Improve Multiple Myeloma Care for Black Patients
This Black Woman is Changing the Face of Clinical Research

This Black Woman is Changing the Face of Clinical Research

Clinical research plays a crucial role in advancing healthcare, but historically, it has lacked diversity both in its workforce and patient populations. Danielle Mitchell, founder and CEO of Black Women in Clinical Research (BWICR), is working to change that. In read more about This Black Woman is Changing the Face of Clinical Research

A Black Doctor Shares Why Lupus Trials Need REAL Representation

Dr. Jessica Williams, MD, MPH, Assistant Professor of Medicine Division of Rheumatology, Washington University School of Medicine and Medical Advisor for Lupus Therapeutics (the research arm for the Lupus Research Alliance) has been deeply engaged in advancing lupus research, especially read more about A Black Doctor Shares Why Lupus Trials Need REAL Representation
Meet the Black Woman Using Clinical Research to Fight Neglected Diseases

This Black Woman Is Using Clinical Research to Fight Neglected Diseases Arriving in the U.S.

As climate change accelerates the spread of tropical diseases into new regions, one organization is working to ensure lifesaving treatments reach those most in need. The Drugs for Neglected Diseases Initiative (DNDi) focuses on developing therapies for often overlooked illnesses read more about This Black Woman Is Using Clinical Research to Fight Neglected Diseases Arriving in the U.S.
lung cancer clinical trials

What Black Americans Need to Know Clinical Trials for Lung Cancer

Lung cancer, or bronchogenic carcinoma, is the collective name for cancers that start in the lungs— usually in the airways (bronchi or bronchioles) or small air sacs (alveoli). Lung cancer is known for its aggressive nature and high mortality rate.  read more about What Black Americans Need to Know Clinical Trials for Lung Cancer

Primary Sidebar

Subscribe to our newsletter

Icon

Caring for You, Too - Caregiver Workbook

1 file(s) 297 KB
Download

Trending Articles

7 Things You Should Never Do To Lose Weight!

lose weight

12 Reasons Why It Feels Like Your Heart Rate Won’t Slow Down

congestive heart failure symptoms

What Is Congestive Heart Failure?

congestive heart failure

5 Reasons Your Hair Texture Changes

hair texture

4 Ways Black Men Show Signs of Anxiety

signs of anxiety
Find a Culturally Sensitive Doctor

Footer

Where Wellness & Culture Connect

BDO is the world’s largest and most comprehensive online health resource specifically targeted to African Americans. BDO understands that the uniqueness of Black culture - our heritage and our traditions - plays a role in our health. BDO gives you access to innovative new approaches to the health information you need in everyday language so you can break through the disparities, gain control and live your life to its fullest.

Connect With Us

Resource Centers

  • Top Blacks in Healthcare
  • Clinical Trials
  • Wellness on the Yard
  • Cancer
  • Immunocompromised Care
  • About Us
  • Privacy Policy
  • Cookie Policy
  • Terms of Service
  • Careers
  • Advertise With Us
  • Advertising & Sponsorship Policy
  • Daily Vitamina
  • TBH

Copyright © 2025, Black Doctor, Inc. All rights reserved.